Antares Pharma, Inc. logo
Antares Pharma, Inc. ATRS
$ 5.59 0.0%

Antares Pharma, Inc. Financial Ratios 2011-2024 | ATRS

Annual Financial Ratios Antares Pharma, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

12.9 -379.0 -74.8 -21.1 -14.0 -8.7 -8.7 -29.5 -36.6 -55.0

P/S

4.9 6.2 7.7 6.5 6.5 3.9 11.5 29.3 18.5 14.7

EV/EBITDA

44.0 221.3 -34.9 -24.5 -14.1 -7.8 -8.0 -27.8 -32.7 -52.0

PEG

0.0 -5.05 -1.17 -0.67 0.98 -0.18 0.13 0.49 0.37 -1.93

P/B

6.1 14.1 12.5 10.5 7.5 2.7 7.4 8.5 4.8 7.8

P/CF

108.5 -59.3 -26.7 -14.5 -16.9 -5.2 -9.6 -33.3 -30.0 -96.3

ROE %

47.18 -3.72 -16.70 -49.91 -53.82 -30.81 -85.33 -29.00 -13.20 -14.09

ROA %

26.44 -1.53 -7.38 -22.52 -36.70 -24.43 -51.11 -23.06 -11.96 -10.46

ROCE %

9.12 0.99 -27.18 -28.07 -51.95 -30.21 -78.83 -28.73 -13.07 -13.88

DSO

122.9 127.6 169.0 79.5 63.4 63.6 48.3 18.3 36.0 56.2

DIO

105.4 115.7 133.4 123.3 67.5 107.4 190.3 256.4 38.4 47.9

DPO

93.7 93.3 130.8 79.2 99.9 97.3 327.2 253.1 109.8 114.9

All numbers in USD currency